The Patent Finder
RD

Roche Diabetes Care, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

924 patents currently held

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
318
Ending by 2030
Nov 2026
Next term end
704
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Reagent Stripe for Test Strip US 7,727,467
Cited by 251 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Nov 2027 · High confidence
Also notable
Management Method and System for Implementation, Execution, Data Collection, and Data Analysis of a Structured Collection Procedure Which Runs on a Collection Device US 9,659,037
Cited by 174 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Ends Jun 2031 · High confidence
Also notable
Medical Software Download to Mobile Phone US 9,811,633
Cited by 65 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Ends Apr 2031 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 4 to 16, 2026 · next Dec 4
  • 13 fees due Jan 7 to 28, 2027 · next Jan 7
  • 12 fees due Feb 1 to 28, 2027 · next Feb 1
  • 15 fees due Mar 1 to 24, 2027 · next Mar 1
  • 16 fees due Apr 1 to 29, 2027 · next Apr 1
  • 8 fees due May 3 to 26, 2027 · next May 3
  • 20 fees due Jun 1 to 30, 2027 · next Jun 1
  • 12 fees due Jul 5 to 28, 2027 · next Jul 5
  • 18 fees due Aug 2 to 27, 2027 · next Aug 2
  • 13 fees due Sep 3 to 30, 2027 · next Sep 3
  • 6 fees due Oct 2 to 30, 2027 · next Oct 2
  • 1 fee due Nov 5, 2027
    The maintenance fee for Implant Needle and Method for Production (US 10,639,070) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • Oct 23Assignment recorded on 1 record: Galley, Paul Joseph to Roche Diabetes Care, Inc. Recorded Oct 23, 2026, executed Jul 25, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76477, frame 611.
  • 17 of the patents on this record were granted since Aug 22, 2026
  • 12 terms have ended since Aug 22, 2026

What they patent

The largest of its 704 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,663,442System and Method for Analyte Measurement Using Dose Sufficiency Electrodes
In force
 · High confidence
In forceHigh confidence
US 8,997,330Layered Sensor for Determining an Analyte Concentration
In force
 · High confidence
In forceHigh confidence
US 8,187,453Triglyceride and Cholesterol Sensing Method and Sensor
In force
 · High confidence
In forceHigh confidence
US 7,569,126System and Method for Quality Assurance of a Biosensor Test Strip
In force
 · High confidence
In forceHigh confidence
US 8,009,014Device and Method for Identifying a User of a Medical Device
In force
 · Medium confidence
In forceMedium confidence
US 7,763,470Test Element and Method of Use for Analyzing Body Fluids
In force
 · High confidence
In forceHigh confidence
US 7,718,439System and Method for Coding Information on a Biosensor Test Strip
In force
 · High confidence
In forceHigh confidence
US 7,435,246System and Device for Removing Pharmaceutical Products
In force
 · High confidence
In forceHigh confidence
US 9,744,295Rotatable Infusion Set
In force
 · Medium confidence
In forceMedium confidence
US 7,998,407Measurement System for Measuring Substance Concentrations in Liquid Media
In force
 · High confidence
In forceHigh confidence
10 of 924 patents shown.
Pro members see all 924.
Pro members: see all 924 patents
Also on record, not counted in the 924: 8 patents in force now held by others · 675 patents ended · 122 applications pending · 349 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited